Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Font Size

New Oral RA Drug Works in Unique Way

Study: Tofacitinib Improves Symptoms in Patients Who Have Not Responded to Other Drugs

Tofacitinib Study Details continued...

At the 12-month mark, nearly 37% of those in the higher-dose drug group had a 50% improvement. And 16% of those on the higher dose had a 70% improvement. In contrast, only 3% of those on placebo got the 70% improvement.

The drug's effects were seen after two weeks of therapy, according to the researchers.

In the drug's study, side effects included infections, but most were mild, Kremer says. As for the four deaths, Kremer says, "After reviewing all the source documents on this case, it appears to me that one of the four deaths could have been related to the drug." In a separate analysis, the researchers looked at 610 patients and found both doses had "clinically significant efficacy and acceptable safety."

Victoria Davis, a Pfizer spokeswoman, says the company plans to file for FDA approval for the drug by the end of 2011.

New RA Drug: Perspective

The drug data look good, says Yusuf Yazici, MD, assistant professor of medicine and a rheumatologist at New York University's Langone Medical Center. He reviewed the study findings for WebMD but was not involved in the study. "It looks like it works."

''The results are similar to what we saw with other [RA drugs],'' says Yazici.

Whether the new oral RA drug, if approved, will become more popular than other RA drugs is not known, Yazici says. It may simply become one more option for RA patients, giving more of a choice, he says.

Kremer reports research and grant support from Pfizer and serving as a company consultant. Yazici reports serving as a consultant for Pfizer, Merck, and other companies.

1 | 2

Today on WebMD

rubbing hands
Avoid these 6 common mistakes.
mature couple exercising
Decrease pain, increase energy.
mature woman threading needle
How much do you know?
Swelling, fatigue, pain, and more.
Lucille Ball
Hand bones X-ray
prescription pills
Woman massaging her neck
woman roasting vegetables in oven
Woman rubbing shoulder
doctor and patient hand examination